Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Overactive Bladder

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Am J Obstet Gynecol.

Savoie MB, Lee KA, Subak LL, Hernandez C, Schembri M, Fung CH, Grady D, Huang AJ

doi: 10.1016/j.ajog.2019.12.005.

Overactive Bladder

Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience

Urologia.

Tamburro FR, Castellan P, Neri F, Berardinelli F, Bada M, Sountoulides P, Giuliani N, Finazzi Agrò E, Schips L, Cindolo L

doi: 10.1177/0391560318759258.

Overactive BladderMenopause

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Eur J Obstet Gynecol Reprod Biol.

Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A

doi: 10.1016/j.ejogrb.2018.01.002.

Overactive BladderUrinary Incontinence

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis

J Obstet Gynaecol Res.

Schiavi MC, Faiano P, D'Oria O, Zullo MA, Muzii L, Benedetti Panici P

doi: 10.1111/jog.13541.

Overactive Bladder

Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled Trial

Urology.

Chen H, Wang F, Yu Z, Zhang Y, Liu C, Dai S, Chen B, Lv J

doi: 10.1016/j.urology.2016.11.008.

Erectile and Sexual Functions and DysfunctionsOveractive Bladder

OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome

Eur J Obstet Gynecol Reprod Biol.

Balzarro M, Rubilotta E, Braga A, Bassi S, Processali T, Artibani W, Serati M

doi: 10.1016/j.ejogrb.2018.05.002.

Overactive Bladder

Vaginal Estrogen Therapy Is Associated with Increased Lactobacillus in the Urine of Post-Menopausal Women with Overactive Bladder Symptoms

Am J Obstet Gynecol.

Thomas-White K, Taege S, Limeira R, Brincat C, Joyce C, Hilt EE, Mac-Daniel L, Radek KA, Brubaker L, Mueller ER, Wolfe AJ

doi: 10.1016/j.ajog.2020.08.006.

Overactive Bladder

Efficacy of Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder in Women and Men at a Safety-Net Hospital

J Urol.

Jiang JF, Leung AK, Pettitt-Schieber B, Nabavizadeh R, Thomas RL, Brown M, Hafford D, Lay AH, Hammett J, Carney KJ, Filson CP, Master VA

doi: 10.1097/

Overactive Bladder

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Eur Urol.

Chapple CR, Cruz F, Cardozo L, Staskin D, Herschorn S, Choudhury N, Stoelzel M, Heesakkers J, Siddiqui E

doi: 10.1016/j.eururo.2019.09.024.

Related content

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis

Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled Trial

OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome

Vaginal Estrogen Therapy Is Associated with Increased Lactobacillus in the Urine of Post-Menopausal Women with Overactive Bladder Symptoms

Efficacy of Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder in Women and Men at a Safety-Net Hospital

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo